PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Wei Zhuang

Department of Medical Oncology, and National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Chinese Acade

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 5, 2026 · JOURNAL ARTICLE

Comparative safety profiles of antibody-drug conjugates: a real-world analysis of monotherapy and combination regimens in solid tumors.

Drug Delivery

Large real-world pharmacovigilance study of 19,697 adverse event reports confirms known structure-toxicity relationships for ADCs, but lacks comparative efficacy data and uses observational methods without prospective controls.

Important Confirmatory EvidenceJie Wang Linjie Fan Combination Therapy

Reported

Sample size (adverse event report…19,697

Number of ADCs analyzed7

Study periodQ1 2004 to Q1 2025

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support